JANUARY

Sameh Mikhail, MD

Chief Fellow Georgetown University Hospital Division of Hematology and Oncology

The Use of Cell Cycle Inhibitors in Gastrointestinal Cancers

Gordon B. Mills, MD, PhD

Professor and Chairman  - Department of Systems Biology UT MD Anderson Cancer Center

                
Functionalizing the Cancer Genome: A Mutation Driven View

FEBRUARY

David R. Jones, MD    

Professor of Surgery

University of Virginia

Introduction of Molecularly-targeted Therapies for Lung Cancer by Surgeons: A New Paradigm?

Adam Goldfarb, MD

Professor of Pathology

Associate Director of Clinical Hematology Laboratory
 
University of Virginia

Molecular Mechanisms Mediating Megakaryocyte Morphogenesis and Malignancy

Stuart S. Berr, Ph.D.
Professor of Research
Radiology and Biomedical Engineering University of Virginia

 Visible Light Imaging in Cancer Research

MARCH

Kimberly Stegmaier, MD

Assistant Professor of Pediatrics

Boston Children's Hospital

Modulating Aberrant Transcription factors in Pediatric Cancers

Professor of Medicine , Endocrinology and Metabolism
University of Virginia

What do Growth Kinetic Models Tell Us About Breast Cancer Prevention and Menopausal Hormone Therapy?

No Seminar - Spring Break

APRIL

Andrew Larner, MD, PhD
Program co-leader of Cancer Cell Signaling
Martha Anne Hatcher Distinguished Professor in Oncology

VCU Massey Cancer Center

The Role of the Jak/Stat Pathway in Mitochondrial Function and Breast Cancer

Adam Goldfarb, MD

 Coordinator IMI Project PREDECT - Paris, France

Why 90% of Anticancer Drugs fail in the Clinic. Some Solutions through Public-Private Initiatives

Victor Lobanenkov, PhD

Chief Molecular Pathology Section Laboratory of Immunogenetics

National Institutes of Health

Next Generation of CTCF and BORIS Studies in Germ, Stem, and Cancer Cells

MAY

Date

Ben Neel, PhD, MD

Director and Senior Scientist - Ontario Cancer Institute

Shp2 and its Binding Proteins in Health and Disease

This seminar is co-sponsored by the Cancer Center and the Department of Microbiology, Immunology, and Cancer Biology

Mythreye S. Karthikeyan, PhD

Assistant Professor - Department of Medicine

Duke University

Beyond Coreception: TGF-β coreceptors in Breast and Ovarian Cancer

James M. Lindberg, M.D.

General Surgery Resident

Surgical Oncology Research Fellow

University of Virginia

From man to mouse to man – Emerging targeted therapies from orthotopic xenograft models of pancreatic cancer

Ali El Sayed , MD

Hematology - Oncology Fellow

University of Virginia

Targeting EGFR and Src in Triple Negative and Hormone-Resistant Breast Cancer